A Retrospective Analysis of the Palliative Surgical Treatment in Patients with Malignant Pleural Effusion

1. Penz E, Watt KN, Hergott CA, Rahman NM, Psallidas I. Management of malignant pleural effusion: challenges and solutions. Cancer Manag Res. 2017;9:229-241.10.2147/CMAR.S95663549157028694705Search in Google Scholar

2. Ried M, Hofmann HS. The treatment of pleural carcinosis with malignant pleural effusion. Dtsch Arztebl Int. 2013;110(18):313-318.10.3238/arztebl.2013.0313365996123720697Search in Google Scholar

3. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ; BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65 Suppl 2:ii32-ii40.10.1136/thx.2010.13699420696691Search in Google Scholar

4. Dixit R, Agarwal KC, Gokhroo A, et al. Diagnosis and management options in malignant pleural effusions. Lung India. 2017;34(2):160-166.10.4103/0970-2113.201305535135928360465Search in Google Scholar

5. Habal P, Omran N, Jankovičová K, Kodělková K, Krejsek J, Manďák J. Torakoskopicky navozená chemická pleurodéza v léčbě maligního pleurálního výpotku. Onkologie. 2014;8(1):35-8.Search in Google Scholar

6. Sahn SA, Huggins JT. Malignant pleural effusions. In: Grippi MA, editors. Fishman's pulmonary diseases and disorders. 5th ed. NewYork: McGraw Hill Education;2015. p. 1164-1187.Search in Google Scholar

7. Jany B, Welte T. Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment. Dtsch Arztebl Int. 2019;116(21):377-386.10.3238/arztebl.2019.0377664781931315808Search in Google Scholar

8. Meriggi F. Malignant Pleural Effusion: Still a Long Way to Go. Rev Recent Clin Trials. 2019;14(1):24-30.10.2174/157488711466618120410520830514193Search in Google Scholar

9. Skok K, Hladnik G, Grm A, Crnjac A. Malignant Pleural Effusion and Its Current Management: A Review. Medicina (Kaunas). 2019;55(8):490.10.3390/medicina55080490672353031443309Search in Google Scholar

10. Huťka Z. Karcinóm pľúc z pohľadu cytopatologickej diagnostiky. In: Kavcová E, Halašová E, Dzian A, editors. Karcinóm pľúc. UK Bratislava, JLF Martin; 2010. p. 216-224.Search in Google Scholar

11. Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M et al. ERS/EACTS statement on the management of malignawnt pleural effusions. Eur J Cardiothorac Surg. 2019;55:116-32.10.1093/ejcts/ezy25830060030Search in Google Scholar

12. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J. 1997;10(8):1907-1913.10.1183/09031936.97.100819079272937Search in Google Scholar

13. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000;162(5):1987-2001.10.1164/ajrccm.162.5.ats8-0011069845Search in Google Scholar

14. Villanueva AG. Management of Malignant Pleural Effusions. Principles and Practice of Interventional Pulmonology. 2012;665-674.10.1007/978-1-4614-4292-9_64Search in Google Scholar

15. Rice TW, Rodriguez RM, Barnette R, Light RW. Prevalence and characteristics of pleural effusions in superior vena cava syndrome. Respirology. 2006;11(3):299-305.10.1111/j.1440-1843.2006.00841.x16635088Search in Google Scholar

16. Plutinský J. Karcinóm pľúc a postihnutie pleury. In: Kavcová E, Halašová E, Dzian A, editors. Karcinóm pľúc. UK Bratislava, JLF Martin; 2010. p. 263–293.Search in Google Scholar

17. Heffner JE. Diagnosis and management of malignant pleural effusions. Respirology. 2008;13(1):5-20.10.1111/j.1440-1843.2008.01306.xSearch in Google Scholar

18. Ludwig C, Stoelben E. Chirurgische Therapie des malignen Pleuraergusses. Zentralblatt für Chirurgie. 2008;133(3):218-221.10.1055/s-2008-107678818563684Search in Google Scholar

19. Koegelenberg CFN, Shaw JA, Irusen EM, Lee YCG. Contemporary best practice in the management of malignant pleural effusion. Ther Adv Respir Dis. 2018;12.10.1177/1753466618785098604865629952251Search in Google Scholar

20. Feller-Kopman D, David J. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practise Guideline. American Journal of Respiratory and Critical Care Medicine. 2018; 198(7):839-349.10.1164/rccm.201807-1415ST30272503Search in Google Scholar

21. Bell D, Wright G. A retrospective review of the palliative surgical management of malignant pleural effusions. BMJ Support Palliat Care. 2014;4(2):161-166.10.1136/bmjspcare-2012-00034224644166Search in Google Scholar

22. Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [published correction appears in Ann Oncol. 2019 May;30(5):863-870]. Ann Oncol. 2018;29(Suppl 4):iv192-iv237.10.1093/annonc/mdy27532169226Search in Google Scholar

23. Bhatnagar R, Laskawiec-Szkonter M, Piotrowska HEG, et al. Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial. BMJ Open. 2014;4:e007045.10.1136/bmjopen-2014-007045424808625428632Search in Google Scholar

24. Clive AO, Kahan BC, Hooper CE, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69(12):1098-1104.10.1136/thoraxjnl-2014-205285425130625100651Search in Google Scholar

25. Abrão FC, de Abreu IRLB, de Oliveira MC, et al. Prognostic factors of recurrence of malignant pleural effusion: what is the role of neoplasia progression? J Thorac Dis. 2020;12(3):813-822.10.21037/jtd.2020.01.13713909932274148Search in Google Scholar